TECOGEN INC. — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
On June 26, 2026, Tecogen's Board approved equity grants and salary increases for five named executives. CEO Abinand Rangesh received 174,081 restricted shares and 26,041 stock options (exercise price $5.17/share); his base salary increased 5% to $220,500. Four other executives (Panora, Deschenes, Lafaille, Whiting) received restricted stock grants (9,671–29,013 shares each) and/or option grants (26,041 shares), with 3% salary increases ranging from $152,260–$206,000. All equity vests over four years.
Why this rating
Routine equity grants (~287k shares, ~3.4% dilution of ~$84.2M market cap = ~$15–18M notional value at $5.17 strike). Salary increases modest (3–5%). Standard annual compensation refresh; no material business change.
Extracted items
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.